Clinical trials: Hypergastrinaemia

Barrett's Esophagus

YF476 in Barrett's Esophagus

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

A phase 2, randomised, double-blind, out-patient trial to determine if YF476 is a safe and effective treatment in patients with Barrett's esophagus.

Trial name

NCT02597712

Testing

YF476

Where

2 sites in United States, United Kingdom

Volunteers

27 people

Sponsor

Trio Medicines Ltd.